<DOC>
	<DOCNO>NCT02293746</DOCNO>
	<brief_summary>The purpose study obtain additional safety efficacy data use Inspire® therapy treatment subject moderate severe Obstructive Sleep Apnea .</brief_summary>
	<brief_title>Inspire® Upper Airway Stimulation ( UAS ) System German Post-Market Study</brief_title>
	<detailed_description>This multi-center , prospective , single-arm study conduct common implant follow-up protocol . Each subject serve control . The study collect pre-operative two-night home sleep testing , medical history subject quality life measure . Intra- post- operative procedure data collect . Therapy usage device adjustment data , well subject satisfaction therapy survey , collect additional analysis . Post-implant , procedure- device-related event , QoL questionnaires , therapy usage device adjustment data collect . Sleep study data collect 2-month visit , conduct , 3-month visit use single night in-lab titration PSGs At 6 12 month post-implant , 2-night home sleep test complete . Safety data collect throughout study . Subjects exit study follow 12-month visit . The subject population consist otherwise healthy men woman least 21 year old : 1 ) Provided write informed consent participate , 2 ) Indicated willingness comply study requirement specify follow-up duration , 3 ) Met inclusion exclusion criterion protocol . Up 60 subject implant 5 site Germany .</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>1 . Likely suffer moderatetosevere OSA base history physical , establish diagnosis OSA ( ≥ 15 AHI &lt; 65 ) base prior sleep test 2 . Willing capable stimulation hardware permanently implant , use patient programmer activate stimulation 3 . Willing capable return followup visit conduct sleep study home , include evaluation procedure fill questionnaire 4 . Willing capable providing inform consent Contraindications 1 . Any anatomical finding would compromise performance upper airway stimulation , presence complete concentric collapse soft palate 2 . Have condition procedure compromise neurological control upper airway 3 . Unable necessary assistance operate patient programmer 4 . Pregnant plan become pregnant 5 . Require magnetic resonance imaging ( MRI ) 6 . Have implantable device may susceptible unintended interaction Inspire system . Additional exclusion study purpose : 7 . Body Mass Index ( BMI ) &gt; 35 8 . Central + mixed apnea &gt; 25 % total apneahypopnea index ( AHI ) 9 . Any chronic medical illness condition contraindicate surgical procedure general anesthesia , judge clinical study Investigator 10 . Has terminal illness life expectancy &lt; 12 month 11 . Active psychiatric disease ( psychotic illness , major depression , acute anxiety attack ) prevents subject compliance requirement investigational study test 12 . Any reason investigator deems subject unfit participation study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>OSA</keyword>
	<keyword>neurostimulation</keyword>
	<keyword>hypoglossal nerve</keyword>
	<keyword>tongue</keyword>
	<keyword>upper airway stimulation</keyword>
	<keyword>surgery</keyword>
</DOC>